Biofrontera received manufacturing and distribution license
Biofrontera AG announces, that its subsidiary Biofrontera Pharma GmbH received the permission to import pharmaceutical products, clear them for European sales and distribute them.
The responsible district government has inspected the Company, assessing all requirements for granting the manufacturing and distribution license in accordance with the German pharmaceutical law. Biofrontera has sufficient qualified personnel, appropriate rooms and facilities as well as a complex quality management system for importing, approving, storing and distributing pharmaceutical compounds.
The manufacturing license is needed for the European submission of the marketing authorization of BF-200 ALA, planned for the beginning of September. By obtaining the license Biofrontera fulfils another important precondition for a marketing authorization application in the centralized European procedure.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.